July 25, 2014

Cover Story

CEO of the Year

Utah’s business landscape is rich with professionals who have le...Read More

Featured Articles

Did you go Skiing this winter?

Around Utah

Sections

Spotlight
Martin Plaehn

Spotlight
Karen Sendelback

Legal Briefs
Social Media and Employers: Friends or Enemies?

Money Talk
The Case for HSAs

Economic Insight
Time to Show Up

Lessons Learned
Make a Move

TechKnowledge
In the Lab

EntrepreneurEdge
Rent to Own

Business Trends
Back from the Dead

Executive Living
Artful Inspiration

Features
A Breath of Fresh Air

Features
Worst-Case Scenario

Regional Report
Northern Utah

Focus
Measure Up

Industry Outlook
Travel & Tourism

Players
Players

Article

BioFire Diagnostics Begins Clinical Trials of ME Panel

Press Release

July 25, 2014

Salt Lake City – BioFire Diagnostics, LLC, bioMérieux’s molecular biology affiliate, has commenced clinical and analytical studies to evaluate the company’s FilmArray meningitis/encephalitis (ME) panel, with plans to seek both FDA clearance and CE IVD marking.

Infection of the meninges surrounding the brain and spinal cord (meningitis), or of the brain (encephalitis) can have high mortality and morbidity rates depending on the source of infection. Acute bacterial meningitis is a rare, but potentially fatal disease. Conversely, viral meningitis is more common, but typically mild and non-lethal. However, clinical diagnosis of the meningitis syndrome is difficult since their signs and symptoms are virtually indistinguishable. With a run time of about an hour, the comprehensive ME panel requires only 200 microliters of cerebrospinal fluid to test simultaneously for 16 different bacterial, viral, and fungal pathogens known to cause community-acquired meningitis and encephalitis.

“The commencement of studies to evaluate our meningitis test is exciting since the FilmArray has the potential to make a profound impact on treating this fatal disease, where symptoms can appear suddenly and escalate quickly,” said Randy Rasmussen, bioMérieux Corporate vice president of molecular biology and CEO of BioFire Diagnostics.

The clinical study is being conducted at several hospital-based clinical laboratories in the U.S. BioFire expects the FDA submission in 2015. The ME panel will be the fourth clinical diagnostic test to run on the FilmArray System.

Additionally, BioFire will exhibit the FilmArray at booth 1257 during the 2014 American Association of Clinical Chemistry (AACC) annual meeting July 29-31 in Chicago.

 

Utah Business Social
UB Events View All
Sustainable Business Awards 2014Utah Business Event
Nov 13, 2014
Utah Business magazine along with presenting sponsor Big D Construction, premier sponsor Rocky Mo...
Best Companies to Work For 2014Utah Business Event
Dec 11, 2014
Utah Business magazine along with our sponsors Diversified Insurance and Miller Motor Sports Park...
SAMY Awards 2015Utah Business Event
Jan 23, 2015
Utah Business magazine along with Presenting Sponsor Griffin Hill are pleased to present the 201...
Community Events View All
Power of Your Purse
Oct 30, 2014
Please join us for the most anticipated and inspirational gala of the year! Be part of the groun...
Discovery Gateway's Halloween Spooktacular
Oct 31, 2014
Join Discovery Gateway: The Children's Museum of Utah, for its annual SUPER FUN Halloween celebra...

info@utahbusiness.com  |  90 South 400 West, Ste 650 Salt Lake City, Utah 84101   |  (801) 568-0114

Advertise with Utah Business

Submit an Event

* indicates required information
* Event Name:
Price (general):
Website (if applicable):
Coordinator's Name:
Coordinator's Email:
Coordinator's Phone:
Venue Name:
Venue Address:
Venue City:
Venue Zip:
Event Capacity:
Date(s):
to
* Event Description:
  Cancel